Biobanks Market Size, Share & Trends Analysis Report By Product (LIMS, Biobanking Equipment), By Biospecimen Type (Organs, Stem Cells), By Biobank Type (Real, Virtual), By Service, By Application, And Segment Forecasts, 2023 - 2030

Biobanks Market Size, Share & Trends Analysis Report By Product (LIMS, Biobanking Equipment), By Biospecimen Type (Organs, Stem Cells), By Biobank Type (Real, Virtual), By Service, By Application, And Segment Forecasts, 2023 - 2030

Biobanks Market Growth & Trends

The global biobanks market size is expected to reach USD 136.9 billion by 2030, according to a new report by Grand View Research, Inc., registering a CAGR of 8.6% during the forecast period. Biobanks continue to evolve with the introduction of new technologies, such as NGS, and increased focus on genomic medicine. The availability of several types of biospecimens to cater to multiple domains including drug discovery, diagnostics, and others has accelerated the diversification of biorepositories, thereby driving the market. The quality of biospecimens can significantly influence disease testing as well as preclinical and clinical research. Regulatory agencies have played a vital role in spurring the adoption of biobanking services by establishing guidelines for the effective management of samples.

For instance, the U.S. Centers for Disease Control and Prevention (CDC) released guidelines to minimize human hazards while handling COVID-19 samples. This serves as a model for other biorepositories. Furthermore, as the number of research studies and clinical trials related to COVID-19 is increasing, the demand for high-quality biospecimens is expected to significantly increase in the near future, leading to market growth. In addition, population-based cohort studies are facilitated by biorepositories to estimate the actual seroprevalence. Health Catalyst, Inc., through its Touchstone platform, provides national data related to COVID-19 insights. Such factors are anticipated to contribute to the revenue flow in this space.

The ‘BioResource’ was created in October 2021 by RareCan, a Hexham-based healthcare start-up dedicated to improving studies into the uncommon forms of cancer. BioResource will retain samples taken after surgery from cancer patients and make them accessible to researchers across the globe who can use them to cure, prevent, and identify the disease. In December 2021, Newcastle University introduced a new collection of human blood samples and donated human tissue, which could transform efforts to cure rare cancers. The U.K. Biobank has announced that fresh data from a study measuring the range of circulatory metabolomics biomarkers has been added to its database. Nightingale Health, a Finnish business specializing in blood biomarker technologies, conducted the study with 120000 participants.

North America dominated the market with its wide network of centers for biosample storage in the U.S. Moreover, a high number of COVID-19 cases in the U.S. and increased R&D programs have resulted in the establishment of new biorepositories, thereby driving revenue in North America. In Asia Pacific, the market is anticipated to register the fastest growth owing to the ever-expanding pharmaceuticals and clinical research domain across Asian countries. The key players are engaged in expanding their global reach by partnering with global distributors, mergers, and acquisitions of other players, and entering a strategic alliance with research communities.

Biobanks Market Report Highlights

  • The biobanking equipment segment accounted for the maximum revenue share in 2022 owing to the high cost of instruments coupled with an increase in the number of biorepositories
  • The biobanking and repository services segment accounted for the largest revenue share in 2022 due to the higher penetration of these services and the increased need for the preservation of biosamples for developing precision medicine and disease-specific research
  • Human tissues are the most stored sample for clinical research, resulting in the dominance of this sample type in the market
  • The virtual biobanks segment is anticipated to witness the fastest CAGR during the forecast period owing to the growing demand for 3D biospecimens coupled with the need for rare disease data for biomedical research
  • The therapeutics application segment accounted for the largest revenue share in 2022 owing to the growing popularity of cell therapies for cancer treatment
  • Several pharma/biotech companies have established their private banks to support clinical trials and the development of cell therapies, resulting in revenue growth in this segment
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1 Methodology And Scope
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates And Forecast Timeline
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Sample Size For The Study On Biobanks Market:
1.3.5.1 Primary sources:
1.3.5.2 Details of primary research
1.3.5.3 Secondary data sources:
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Market Model
1.7 Objectives
1.7.1 Objective 1:
1.7.2 Objective 2:
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
Chapter 3 Industry Outlook
3.1 Market Dynamics
3.2 Biobanks Market: Market Segmentation
3.3 Market Driver Analysis
3.3.1 Continuous Increase In Covid-19 Cases Along With Capacity Expansion
3.3.2 Increased Focus On Precision Medicine And Genetic Testing
3.3.3 Changes In Biobanking Operations
3.3.4 Increase In The Number Of Clinical Trials Globally
3.3.5 Growing Industry And Research Collaborations
3.3.6 Technology Advancement And Automation
3.4 Market Restraint Analysis
3.4.1 Disruptions In Supply Chain Management Due To Covid-19
3.4.2 Challenges In Sharing Biobanking Data & Limited Access To Biospecimens
3.4.3 Sustainability Challenges For Biobanks
3.4.4 Other Challenges In Biobanking Specimens For Research
3.5 Penetration & Growth Prospect Mapping for Biospecimen Type, 2022
3.6 Biobanks Market - Regulatory Framework
3.7 Role of Biobanking in COVID-19 Crisis
3.8 Biobanks Market - Porter’s Analysis
3.9 Biobanks Market - SWOT Analysis
Chapter 4 Product Business Analysis
4.1 Global Biobanks Market: Product Movement Analysis
4.2 Biobanking Equipment
4.2.1 Global Biobanking Equipment Market, 2018 - 2030 (USD Million)
4.2.2 Temperature Control Systems
4.2.2.1 Global biobanking temperature control systems market, 2018 - 2030 (USD Million)
4.2.2.2 Freezers & refrigerators
4.2.2.2.1 Global biobanking freezers & refrigerators market, 2018 - 2030 (USD Million)
4.2.2.3 Cryogenic storage systems
4.2.2.3.1 Global biobanking cryogenic storage systems market, 2018 - 2030 (USD Million)
4.2.2.4 Thawing equipment
4.2.2.4.1 Global biobanking thawing equipment market, 2018 - 2030 (USD Million)
4.2.3 Incubators & Centrifuges
4.2.3.1 Global biobanking incubators & centrifuges market, 2018 - 2030 (USD Million)
4.2.4 Alarms & Monitoring Systems
4.2.4.1 Global biobanking alarms & monitoring systems market, 2018 - 2030 (USD Million)
4.2.5 Accessories & Other Equipment
4.2.5.1 Global accessories & other biobanking equipment market, 2018 - 2030 (USD Million)
4.3 Biobanking Consumables
4.3.1 Global Biobanking Consumables Market, 2018 - 2030 (USD Million)
4.4 Laboratory Information Management Systems (LIMS)
4.4.1 Global Biobanking Lims Market, 2018 - 2030 (USD Million)
Chapter 5 Service Business Analysis
5.1 Biobanks Market: Service Movement Analysis
5.2 Biobanking & Repository
5.2.1 Global Biobanking & Repository Market, 2018 - 2030 (USD Million)
5.3 Lab Processing
5.3.1 Global Lab Processing Market, 2018 - 2030 (USD Million)
5.4 Qualification/Validation
5.4.1 Global Qualification/Validation Market, 2018 - 2030 (USD Million)
5.5 Cold Chain Logistics
5.5.1 Global Biobanking Cold Chain Logistics Market, 2018 - 2030 (USD Million)
5.6 Other Biobanking Services
5.6.1 Global Other Biobanking Services Market, 2018 - 2030 (USD Million)
Chapter 6 Biospecimen Types Business Analysis
6.1 Biobanks Market: Biospecimen Types Movement Analysis
6.2 Human Tissues
6.2.1 Sales & Distribution Of Tissues Biospecimens
6.2.2 Global Human Tissues Biobanks Market, 2018 - 2030 (USD Million)
6.3 Human Organs
6.3.1 Global Human Organ Biobanking Market, 2018 - 2030 (USD Million)
6.4 Stem Cells
6.4.1 Preservation & Procurement Of Stem Cells
6.4.2 Global Stem Cell Biobanking Market, 2018 - 2030 (USD Million)
6.4.3 Adult Stem Cells
6.4.3.1 Global Adult Stem Cell Biobanking Market, 2018 - 2030 (USD Million)
6.4.4 Embryonic Stem Cells
6.4.4.1 Global Embryonic Stem Cell Biobanking Market, 2018 - 2030 (USD Million)
6.4.5 Induced Pluripotent Stem Cells (Ipscs)
6.4.5.1 Global Ipscs Biobanking Market, 2018 - 2030 (USD Million)
6.4.6 Other Stem Cells
6.4.6.1 Global Other Stem Cell Biobanking Market, 2018 - 2030 (USD Million)
6.5 Other Biospecimens
6.5.1 Global Other Biospecimens Banking Market, 2018 - 2030 (USD Million)
Chapter 7 Biobank Type Business Analysis
7.1 Biobanks Market: Biobank Type Movement Analysis
7.2 Physical/Real Biobanks
7.2.1 Global Physical/Real Biobanks Market, 2018 - 2030 (USD Million)
7.2.2 Tissue Biobanks
7.2.2.1 Global Tissue Biobanks Market, 2018 - 2030 (USD Million)
7.2.3 Population-Based Biobanks
7.2.3.1 Global Population-Based Biobanks Market, 2018 - 2030 (USD Million)
7.2.4 Genetic (Dna/Rna)
7.2.4.1 Global Genetic (Dna/Rna) Biobank Market, 2018 - 2030 (USD Million)
7.2.5 Disease-Based Biobanks
7.2.5.1 Global Disease-Based Biobanks Market, 2018 - 2030 (USD Million)
7.3 Virtual Biobanks
7.3.1 Global Virtual Biobanks Market, 2018 - 2030 (USD Million)
Chapter 8 Application Business Analysis
8.1 Biobanks Market: Biobank Type Movement Analysis
8.2 Therapeutics
8.2.1 Global Biobanks Market For Therapeutics, 2018 - 2030 (USD Million)
8.3 Drug Discovery & Clinical Research
8.3.1 Global Biobanks Market For Drug Discovery & Clinical Research, 2018 - 2030 (USD Million)
8.4 Clinical Diagnostics
8.4.1 Global Biobanks Market For Clinical Diagnostics, 2018 - 2030 (USD Million)
8.5 Other Applications
8.5.1 Global Biobanks Market For Other Applications, 2018 - 2030 (USD Million)
Chapter 9 Regional Business Analysis
9.1 North America
9.1.1 Swot Analysis:
9.1.1.1 North America biobanks market estimates and forecasts, 2018 - 2030 (USD Million)
9.1.2 U.S.
9.1.2.1 Key country dynamics
9.1.2.2 Competitive scenario
9.1.2.3 Regulatory framework
9.1.2.4 U.S. biobanks market estimates and forecasts, 2018 - 2030 (USD Million)
9.1.3 Canada
9.1.3.1 Key country dynamics
9.1.3.2 Competitive scenario
9.1.3.3 Regulatory framework
9.1.3.4 Canada biobanks market estimates and forecasts, 2018 - 2030 (USD Million)
9.2 Europe
9.2.1 Swot Analysis:
9.2.1.1 Europe biobanks market estimates and forecasts, 2018 - 2030 (USD Million)
9.2.2 Germany
9.2.2.1 Key country dynamics
9.2.2.2 Competitive scenario
9.2.2.3 Regulatory framework
9.2.2.4 Germany biobanks market estimates and forecasts, 2018 - 2030 (USD Million)
9.2.3 U.K.
9.2.3.1 Key country dynamics
9.2.3.2 Competitive scenario
9.2.3.3 Regulatory framework
9.2.3.4 UK biobanks market estimates and forecasts, 2018 - 2030 (USD Million)
9.2.4 France
9.2.4.1 Key country dynamics
9.2.4.2 Competitive scenario
9.2.4.3 Regulatory framework
9.2.4.4 France biobanks market estimates and forecasts, 2018 - 2030 (USD Million)
9.2.5 Italy
9.2.5.1 Key country dynamics
9.2.5.2 Competitive scenario
9.2.5.3 Regulatory framework
9.2.5.4 Italy biobanks market estimates and forecasts, 2018 - 2030 (USD Million)
9.2.6 Spain
9.2.6.1 Key country dynamics
9.2.6.2 Competitive scenario
9.2.6.3 Regulatory framework
9.2.6.4 Spain biobanks market estimates and forecasts, 2018 - 2030 (USD Million)
9.2.7 Denmark
9.2.7.1 Key country dynamics
9.2.7.2 Competitive scenario
9.2.7.3 Regulatory framework
9.2.7.4 Denmark biobanks market estimates and forecasts, 2018 - 2030 (USD Million)
9.2.8 Sweden
9.2.8.1 Key country dynamics
9.2.8.2 Competitive scenario
9.7.2.1 Regulatory framework
9.7.2.2 Sweden biobanks market estimates and forecasts, 2018 - 2030 (USD Million)
9.2.9 Norway
9.2.9.1 Key country dynamics
9.2.9.2 Competitive scenario
9.2.9.3 Regulatory framework
9.2.9.4 Norway biobanks market estimates and forecasts, 2018 - 2030 (USD Million)
9.2.10 Switzerland
9.2.10.1 Key country dynamics
9.2.10.2 Competitive scenario
9.2.10.3 Regulatory framework
9.2.10.4 Switzerland biobanks market estimates and forecasts, 2018 - 2030 (USD Million)
9.3 Asia Pacific
9.3.1 Swot Analysis:
9.3.1.1 Asia Pacific Biobanks Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.2 Japan
9.3.2.1 Key Country Dynamics
9.3.2.2 Competitive Scenario
9.3.2.3 Regulatory Framework
9.3.2.4 Japan Biobanks Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.3 China
9.3.3.1 Key Country Dynamics
9.3.3.2 Competitive Scenario
9.3.3.3 Regulatory Framework
9.3.2.3 China Biobanks Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.4 India
9.3.4.1 Key Country Dynamics
9.3.4.2 Competitive Scenario
9.3.4.3 Regulatory Framework
9.3.4.4 India Biobanks Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.5 South Korea
9.3.5.1 Key Country Dynamics
9.3.5.2 Competitive Scenario
9.3.5.3 Regulatory Framework
9.3.5.4 South Korea Biobanks Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.6 Australia
9.3.6.1 Key Country Dynamics
9.3.6.2 Competitive Scenario
9.3.6.3 Regulatory Framework
9.3.6.4 Australia Biobanks Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.7 Thailand
9.3.7.1 Key Country Dynamics
9.3.7.2 Competitive Scenario
9.3.7.3 Regulatory Framework
9.3.7.4 Thailand Biobanks Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.8 Singapore
9.3.8.1 Key Country Dynamics
9.3.8.2 Competitive Scenario
9.3.8.3 Regulatory Framework
9.3.8.4 Singapore Biobanks Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4 Latin America
9.4.1 Swot Analysis:
9.4.1.1 Latin America Biobanks Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4.2 Brazil
9.4.2.1 Key Country Dynamics
9.4.2.2 Competitive Scenario
9.4.2.3 Regulatory Framework
9.4.2.4 Brazil Biobanks Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4.3 Mexico
9.4.3.1 Key Country Dynamics
9.4.3.2 Competitive Scenario
9.4.3.3 Regulatory Framework
9.4.3.4 Mexico Biobanks Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4.4 Argentina
9.4.4.1 Key Country Dynamics
9.4.4.2 Competitive Scenario
9.4.4.3 Regulatory Framework
9.4.4.4 Argentina Biobanks Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5 Middle East And Africa
9.5.1 Swot Analysis:
9.5.1.1 Middle East And Africa Biobanks Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.2 South Africa
9.5.2.1 Key Country Dynamics
9.5.2.2 Competitive Scenario
9.5.2.3 Regulatory Framework
9.5.2.4 South Africa Biobanks Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.3 UAE
9.5.3.1 Key Country Dynamics
9.5.3.2 Competitive Scenario
9.5.3.3 Regulatory Framework
9.5.3.4 Uae Biobanks Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.4 Saudi Arabia
9.5.4.1 Key Country Dynamics
9.5.4.2 Competitive Scenario
9.5.4.3 Regulatory Framework
9.5.4.4 Saudi Arabia Biobanks Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.5 Kuwait
9.5.5.1 Key Country Dynamics
9.5.5.2 Competitive Scenario
9.5.5.3 Regulatory Framework
9.5.5.4 Kuwait Biobanks Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 10 Competitive Landscape
10.1 Participant’s Overview
10.1.1 Thermo Fisher Scientific Inc.
10.1.2 Merck Kgaa
10.1.3 Qiagen
10.1.4 Hamilton Company
10.1.5 Tecan Trading Ag
10.1.6 Danaher Corporation
10.1.7 Becton, Dickinson, and Company (Bd)
10.1.8 Biocision, Llc
10.1.9 Taylor-Wharton
10.1.10 Charles River Laboratories
10.1.11 Lonza
10.1.12 Stemcell Technologies
10.1.13 Biovault Family
10.1.14 Promocell Gmbh
10.1.15 Precision Cellular Storage Ltd. (Virgin Health Bank)
10.2 Financial Performance
10.3 Participant Categorization
10.4 Strategy Mapping
10.4.1 Expansion
10.4.2 Acquisition
10.4.3 Collaborations
10.4.4 Product/Service Launch
10.4.5 Partnerships
10.4.6 Others

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings